Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis

Frontiers in Bioscience

Volumn 12, Issue 12, 2007, Pages 4497-4503

  Oyama, Tsunehiro ^a,b   Sugio, Kenji ^b   Uramoto, Hidetaka ^b   Iwata, Teruo ^b   Onitsuka, Takamitsu ^b   Isse, Toyohi ^a   Nozoe, Tadahiro ^b   Kagawa, Norio ^c   Yasumoto, Kosei ^b   Kawamoto, Toshihiro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aryl hydrocarbon receptor; Bronchial epithelium; Carcinogen; Cytochrome P450; Respiratory tract

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450;

ARTICLE; BRONCHUS; ENZYMOLOGY; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MUTATION; PATHOLOGY; PROGNOSIS; SMOKING; TUMOR SUPPRESSOR GENE;

BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CYTOCHROME P-450 ENZYME SYSTEM; EPITHELIUM; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MUTATION; PROGNOSIS; RECEPTORS, ARYL HYDROCARBON; SMOKING;

EID: 34347249168     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2404     Document Type: Article

References (33)

1. Uramoto, H., R. Nakanishi, Y. Fujino, H. Imoto, M. Takenoyama, T. Yoshimatsu, T. Oyama, T. Osaki & K. Yasumoto: Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer. Thorax, 56, 59-61 (2001) (Pubitemid 32042157)
2. Sobue, T., S. Yamamoto, M. Hara, S. Sasazuki, S. Sasaki & S. Tsugane: Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer, 99, 245-51 (2002) (Pubitemid 34309482)
3. Oyama, T., T. Mitsudomi, T. Kawamoto, A. Ogami, T. Osaki, Y. Kodama & K. Yasumoto: Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health, 67, 253-6 (1995)
4. Oyama, T., T. Kawamoto, T. Mizoue, K. Nishida, T. Osaki, K. Sugio, K. Yasumoto & T. Mitsudomi: p53 mutations of lung cancer are not significantly affected by CYP1A1 or GSTM1 polymorphisms. Int J Oncol, 11, 305-309 (1997) (Pubitemid 27305962)
5. Oyama, T., T. Kawamoto, T. Mizoue, K. Sugio, Y. Kodama, T. Mitsudomi & K. Yasumoto: Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res, 17, 583-7 (1997) (Pubitemid 27105532)
6. Fujieda, M., H. Yamazaki, T. Saito, K. Kiyotani, M. A. Gyamfi, M. Sakurai, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh & T. Kamataki: Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis, 25, 2451-8 (2004) (Pubitemid 39625186)
7. Puga, A., C. R. Tomlinson & Y. Xia: Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol, 69, 199-207 (2005) (Pubitemid 41556566)
8. Safe, S. & V. Krishnan: Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch Toxicol Suppl, 17, 99-115 (1995)
9. Kewley, R. J., M. L. Whitelaw & A. Chapman-Smith: The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol, 36, 189-204 (2004) (Pubitemid 37487755)
10. Kawajiri, K., H. Eguchi, K. Nakachi, T. Sekiya & M. Yamamoto: Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 56, 72-6 (1996) (Pubitemid 26010386)
11. Mitsudomi, T., T. Oyama, T. Kusano, T. Osaki, R. Nakanishi & T. Shirakusa: Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst, 85, 2018-23 (1993) (Pubitemid 24000986)
12. Oyama, T., T. Osaki, N. Nose, Y. Ichiki, M. Inoue, H. Imoto, T. Yoshimatsu, M. Kodate, H. Uramoto, T. Mizoue, K. Yano & K. Yasumoto: Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Anticancer Res, 20, 505-10 (2000) (Pubitemid 30189710)
13. Oyama, T., A. Matsumoto, T. Isse, Y. D. Kim, S. Ozaki, T. Osaki, K. Sugio, K. Yasumoto & T. Kawamoto: Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism. Anticancer Res, 23, 1731-7 (2003) (Pubitemid 36750839)
14. Oyama, T., T. Osaki, T. Baba, Y. Nagata, M. Mizukami, T. So, S. Nakata, Y. Ichiki, H. Uramoto, M. Sugaya, T. Yoshimatsu, M. Morita, T. Hanagiri, K. Sugio, T. Kawamoto & K. Yasumoto: Molecular genetic tumor markers in non-small cell lung cancer. Anticancer Res, 25, 1193-6 (2005) (Pubitemid 40546789)
15. Yoshimatsu, T., H. Uramoto, T. Oyama, Y. Yashima, C. Gu, M. Morita, K. Sugio, K. Kohno & K. Yasumoto: Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Anticancer Res, 25, 3437-43 (2005) (Pubitemid 41105222)
16. Nakata, S., K. Sugio, H. Uramoto, T. Oyama, T. Hanagiri, M. Morita & K. Yasumoto: The methylation status and protein expression of CDH1, p16 (INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Cancer, 106, 2190-9 (2006) (Pubitemid 43673241)
17. Iwata, T., H. Uramoto, K. Sugio, Y. Fujino, T. Oyama, S. Nakata, K. Ono, M. Morita & K. Yasumoto: A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer. Lung Cancer, 50, 67-73 (2005) (Pubitemid 41297471)
18. Osaki, T., T. Oyama, C. D. Gu, T. Yamashita, T. So, M. Takenoyama, K. Sugio & K. Yasumoto: Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I nonsmall-cell lung cancer. J Clin Oncol, 20, 2930-6 (2002) (Pubitemid 34728886)
19. Uramoto, H., K. Sugio, T. Oyama, S. Nakata, K. Ono, T. Nozoe & K. Yasumoto: Expression of the p53 family in lung cancer. Anticancer Res, 26, 1785-90 (2006) (Pubitemid 43989432)
20. Mountain, C. F. & C. M. Dresler: Regional lymph node classification for lung cancer staging. Chest, 111, 1718-23 (1997) (Pubitemid 27260108)
21. Brambilla, E., W. D. Travis, T. V. Colby, B. Corrin & Y. Shimosato: The new World Health Organization classification of lung tumours. Eur Respir J, 18, 1059-68 (2001) (Pubitemid 34092881)
22. Oyama, T., T. Isse, N. Kagawa, T. Kinaga, Y. D. Kim, M. Morita, K. Sugio, H. Weiner, K. Yasumoto & T. Kawamoto: Tissue-distribution of aldehyde dehydrogenase 2 and effects of the ALDH2 gene-disruption on the expression of enzymes involved in alcohol metabolism. Front Biosci, 10, 951-60 (2005)
23. Oyama, T., K. Sugio, H. Uramoto, T. Kawamoto, N. Kagawa, S. Nadaf, D. Carbone & K. Yasumoto: Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front Biosci, 12, 2299-308 (2007)
24. Oyama, T., T. Osaki, T. Mitsudomi, R. Ogawa, R. Nakanishi, K. Sugio & K. Yasumoto: p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors. Int J Mol Med, 1, 823-6 (1998)
25. Shimada, T., H. Yamazaki, M. Mimura, Y. Inui & F. P. Guengerich: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther, 270, 414-23 (1994) (Pubitemid 24229655)
26. Hukkanen, J., O. Pelkonen, J. Hakkola & H. Raunio: Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol, 32, 391-411 (2002) (Pubitemid 35191358)
27. Berge, G., S. Mollerup, O. V. S. A. Hewer, D. H. Phillips, E. Eilertsen & A. Haugen: Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer, 45, 289-97 (2004) (Pubitemid 39037710)
28. Port, J. L., K. Yamaguchi, B. Du, M. De Lorenzo, M. Chang, P. M. Heerdt, L. Kopelovich, C. B. Marcus, N. K. Altorki, K. Subbaramaiah & A. J. Dannenberg: Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis, 25, 2275-81 (2004) (Pubitemid 39534867)
29. Crawford, E. L., D. A. Weaver, J. P. DeMuth, C. M. Jackson, S. A. Khuder, M. W. Frampton, M. J. Utell, W. G. Thilly & J. C. Willey: Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis, 19, 1867-71 (1998) (Pubitemid 28474654)
30. Runge, D. M., T. W. Stock, T. Lehmann, C. Taege, U. Bernauer, D. B. Stolz, S. Hofmann & H. Foth: Expression of cytochrome P450 2E1 in normal human bronchial epithelial cells and activation by ethanol in culture. Arch Toxicol, 75, 335-45 (2001) (Pubitemid 32757415)
31. Raunio, H., J. Hakkola & O. Pelkonen: Regulation of CYP3A genes in the human respiratory tract. Chem Biol Interact, 151, 53-62 (2005) (Pubitemid 40208557)
32. Lin, J. H.: CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res, 23, 1089-116 (2006) (Pubitemid 43946134)
33. Zhang, J. Y., Y. Wang & C. Prakash: Xenobioticmetabolizing enzymes in human lung. Curr Drug Metab, 7, 939-48 (2006)